SHUKRA MEDTECH LIMITED (BOM:524632)
79.97
+0.06 (0.08%)
At close: Nov 6, 2026
SHUKRA MEDTECH LIMITED Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 443.21 | 220.58 | 95.75 | 185.37 | 44.07 | 7.51 |
Depreciation & Amortization | 40.45 | 34.43 | 30.05 | 20.5 | 18.38 | 16.62 |
Other Operating Activities | 172.03 | 44.84 | -8.85 | 2.21 | -4.5 | 0.8 |
Change in Accounts Receivable | -345.21 | -141.81 | 157.46 | 56.74 | -227.86 | 23.47 |
Change in Inventory | -75.2 | -39.5 | -76.39 | 8.42 | 7.97 | -22.72 |
Change in Accounts Payable | 45.84 | 8.49 | 19.95 | -261.51 | 260.97 | 32.61 |
Change in Other Net Operating Assets | -267.66 | -87.72 | -138.79 | -63.7 | -67.33 | 21.6 |
Operating Cash Flow | 13.46 | 39.31 | 79.18 | -51.97 | 31.7 | 79.89 |
Operating Cash Flow Growth | - | -50.35% | - | - | -60.32% | 1386.79% |
Investing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -301.72 | -157.3 | -27.43 | -17.6 | -44.91 | -15.5 |
Investment in Securities | - | - | - | - | - | -0.09 |
Other Investing Activities | 11.14 | 15.87 | 14.79 | 5.59 | 0.64 | 0.31 |
Investing Cash Flow | -290.58 | -141.43 | -12.64 | -12.01 | -44.27 | -15.28 |
Financing Activities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | 0.8 | 4.56 | - | 6.42 | - |
Long-Term Debt Repaid | - | - | - | -11.12 | - | -63.94 |
Net Debt Issued (Repaid) | 179.93 | 0.8 | 4.56 | -11.12 | 6.42 | -63.94 |
Issuance of Common Stock | 77.56 | - | - | 138.72 | 46.28 | - |
Common Dividends Paid | - | -4.38 | -43.79 | -0.7 | -0.73 | - |
Other Financing Activities | -3.74 | 44.28 | -5.95 | -2.85 | -2.56 | -2.81 |
Financing Cash Flow | 253.75 | 40.7 | -45.18 | 124.05 | 49.41 | -66.75 |
Net Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | 0 | - | 0 | - | - |
Net Cash Flow | -23.37 | -61.41 | 21.37 | 60.08 | 36.84 | -2.15 |
Free Cash Flow
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -288.26 | -117.99 | 51.75 | -69.57 | -13.22 | 64.39 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -25.86% | -20.80% | 15.81% | -9.28% | -2.22% | 31.43% |
Free Cash Flow Per Share | -0.64 | -0.27 | 0.12 | -0.16 | -0.20 | 1.03 |
Levered Free Cash Flow | -343.13 | -137.74 | 32.25 | -123.17 | -43.52 | 57.98 |
Unlevered Free Cash Flow | -335 | -130.91 | 35.51 | -121.45 | -41.92 | 59.74 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 9.64 | 9.64 | 5.95 | 2.85 | 2.56 | 2.81 |
Cash Income Tax Paid | 16.22 | 16.22 | 37.62 | 6.25 | 2.5 | 4.37 |
Change in Working Capital | -642.23 | -260.54 | -37.77 | -260.05 | -26.24 | 54.96 |